Fig. 5

Drug eluting implants address dental implants’ soft-tissue integration (STI) challenges. Scheme showing a dental implant and transmucosal region; b peri-implantitis; c surface modification to achieve STI; and d next generation of modified therapeutic implants releasing active drugs/proteins directly inside the transmucosal region. Adapted with permission from ref. 93